NEWS
Viroclinics Biosciences and DDL Diagnostic Laboratory Join Forces
Viroclinics Biosciences, a leading virology contract research organization, announced today that it has acquired DDL Diagnostic Laboratory, a leading diagnostic solutions provider. The transaction enhances the combined group’s leading global position in anti-viral and vaccine testing and will serve to accelerate their ambitious growth strategy.
Viroclinics Xplore Joins Trade Mission Life Sciences India
October 13th - October 19th, Delhi & Bangalore Viroclinics Xplore continues its cooperation with The Netherlands Enterprise Agency (RVO). Viroclinics experts will join the upcoming trade mission to India from October 13th to October 19th. The health program of the...
Launch Viroclinics Xplore Business Unit
Due to the growing demand of our global business and the drive to deliver innovative diagnostic services, we are proud to announce the launch of our new business unit, Viroclinics Xplore.
Swift regulatory submission guaranteed with eCTD platform
To enable and assist our clients with a hassle-free submission process, it was decided to contract Zwiers Regulatory Consultancy as our main strategic regulatory partner.
Hitting multiple targets with Viroclinics Biosciences’ Rhino and Entero diagnostics platform
In this case study article Viroclinics Biosciences‘ team member Saskia Smits sheds light on a customized research model, designed to tackle the challenge of typing multiple Rhino- and Enteroviruses.
Keep up-to-date
Subscribe to our newsletter for the latest insights on early stage, (pre)clinical research, cold chain logistics and assay development services.
